Dr Lal Pathlabs

Vijaya Diagnostic Centre IPO opens next week; check grey market premium, price band, lot size, bid details

Vijaya Diagnostic Centre Rs 1,895-crore IPO will open for subscription on 1 September, at a price band of Rs 522-531 per share of the face value of Re 1, each.

Vijaya Diagnostic IPO, Vijaya Diagnostic IPO price band

Vijaya Diagnostic Centre IPO opens September 1; issue entirely an OFS

Vijaya Diagnostic Centre IPO will open for subscription on 1 September 2021 and close on 3 September.

IPO, Vijaya Diagnostic Centre, public issue

Krsnaa Diagnostics IPO share allotment: Check status online, grey market premium, listing day strategy

Krsnaa Diagnostics, whose IPO saw 64.40 times subscription, is likely to finalise the share allotment on Thursday, 12 August 2021.

Krsnaa Diagnostics, IPO

Analyst Corner: ‘Hold’ on Dr Lal Pathlabs with DCF-based target price of Rs 3,405

However, considering recent rally in the stock price which has made valuations fair, we downgrade it to HOLD from Add.

Dr Lal witnessed another quarter of strong growth with 128/41% YoY/QoQ growth.

Krsnaa Diagnostics IPO opens August 4; check price band, grey market premium, IPO size, listing date

Krsnaa Diagnostics Rs 1,213-crore IPO will open for subscription on Wednesday, 4 August 2021, at a price band of Rs 933-954 per share of face value of Rs 5 each.

Krsnaa Diagnostics, IPO, Devyani International, Windlas Biotech, Exxaro Tiles

‘To reach 2.5% of GDP spend, healthcare sector does not need a gradual but a quantum jump’

On the slow pace of vaccination Mishra did mention supply bottlenecks, vaccine hesitancy & ability to reach the arm as the primary reasons but at the same time sounded optimistic that if we become more methodical, India has t

Adding on to Mishra comments, Dr Lal also said that for the government to reach this magic figure of 2.5% of GDP by 2025, there needs to be additional spend of 1.2 lakh crore on heath every year.

Krsnaa Diagnostics files IPO papers with Sebi; firm receives heavy demand for PCR testing amid COVID-19

Krsnaa Diagnostics filed draft papers with the market regulator Securities and Exchange Board of India (Sebi) for an initial public offering (IPO)

Krsnaa Diagnostics, COVID-19, IPO

Technical stock picks for 2021: Buy these 7 shares; charts signal as high as 30% rally next year

Over the past four decades, global equities have always generated positive returns in a year following US elections, wherein BSE Sensex gained an average 37 per cent

Indigo paints, ipo, initial public offer

Top stocks to buy post SEBI ruling: 5 high conviction midcap stocks with strong fundamentals, growth potential

The brokerage firm has prepared a basket of five high conviction midcap stocks which are fundamentally sound with good growth potential, with an equal weightage of 20 per cent.

US Stocks, Wall Street, sectors, energy, travel, financials, U.S. presidential election, oil, dollar

Dr Lal PathLabs shares gain today on expansion plans; up 80% since listing

Dr Lal PathLabs shares jumped over 2 per cent in the early trade on Friday on reports that the diagnostic services provider is planning to expand its footprint across India.

Gayatri Projects’ JV wins contract worth Rs 1255 crore, shares surge 17 per cent

Muthoot Finance, Jubilant FoodWorks among 10 stocks that remained in focus in Monday’s trade

Muthoot Finance shares closed 8.72 per cent up at Rs 233.85 after the company reported 60.56 per cent rise in net profit figures at Rs 265.22 crore for the quarter ended March 31, 2016.

As Nifty ends below 8,900, these 65 stocks hit fresh 52-week high in Friday's trade

Dr Lal PathLabs to acquire Delta Ria and Pathology

Diagnostic chain Dr Lal PathLabs today said it will fully acquire Delta Ria and Pathology while increasing its stake in group firms Paliwal Diagnostics and Paliwal Medicare by 10 per cent each.

Dr Lal PathLabs Q4 net profit up 20 pct at Rs 34.44 crore

Diagnostic chain Dr Lal PathLabs today reported 19.79 per cent rise in consolidated net profit at Rs 34.44 crore for the quarter ended March 31, 2016.

dr lal pathlabs ipo

Dr Lal, Alkem shares extend gains for second day after blockbuster listing

Share price of diagnostic chain Dr Lal PathLabs and drug major Alkem Laboratories surged 8.43 per cent and 10.16 per cent to Rs 893.65 and Rs 1521.75, respectively on Thursday.(Photo: Reuters)

Stocks in focus

Alone and loving it: Lal Pathlabs and five other stock singles

After the success of Dr Lal Pathlabs, we take a look at some companies which are the only listed ones in their category.

Stocks in focus today

Dr Lal PathLabs surges 52%, Alkem Labs gains 31% on market debut

Alkem Laboratories shares opened 31.42 per cent up from its issue price of Rs 1,050 on BSE. Dr Lal Pathlabs opened 30.36 per cent up from its issue price of Rs 550.

Midcap stocks to bet

After Alkem and Dr Lal IPOs, Narayana Hrudayalaya set to hit market next week

Narayana Hrudayalaya is set to hit Dalal Street with its initial public offer (IPO) on December 17.

IPOs of Dr Lal PathLabs, Alkem fully subscribed

Despite volatility in the secondary markets, initial public offerings (IPO) of Alkem Laboratories and Dr Lal PathLabs managed to get fully subscribed on the second day of the three-day issue.

Dr Lal PathLabs subscribed 0.65 times

The initial public offering (IPO) of Dr Lal PathLabs was subscribed 0.65 times on the first day of three day offering.

Dr Lal PathLabs IPO hits market: Should you subscribe or avoid?

Dr Lal PathLabs' price band for the offer has been fixed at Rs 540-550 per share and the allotment to anchor investors has been done at the higher end.

dr lal pathlabs ipo

Dr Lal PathLabs mops up Rs 191 cr in pre-IPO placement

Dr Lal PathLabs plans to raise Rs 638 crore through the issue based on the upper price band

Alkem Laboratories, Dr Lal Pathlabs IPOs hit markets; all you need to know

Dalal Street is set to witness two initial public offers (IPOs) this week from pharma and healthcare related companies - Alkem Laboratories and Dr Lal Pathlabs — on December 8.

Quess Corp IPO

Dr Lal PathLabs fixes IPO price band at Rs 540-550

Diagnostic chain Dr Lal PathLabs today fixed price band at Rs 540-550 for its initial public offer (IPO) which will hit the capital market on December 8.

Lupin shares, bse sensex

Dr Lal PathLabs gets Sebi nod for IPO

Kotak Mahindra Capital and Citigroup Global Markets India are the book running lead managers for the IPO.

dr lal pathlabs ipo

Dr Lal PathLabs plans IPO; files draft papers with Sebi

Diagnostic chain Dr Lal PathLabs is planning to go public and has filed draft papers with market regulator Sebi to raise funds through an IPO.

Quess Corp IPO

Dr Lal PathLabs announces expansion plans in Bengaluru city

Aims to open 50 centres and laboratories by December 2015 Dr Lal PathLabs is unveiling a series of initiatives designed to cater to the diagnostic testing requirements of the city. This will fulfil the anticipated business gr

Income Tax Calculator, Budget 2019, How to Calculate Income Tax

US Stock Market

View All


Stock Market

Most Read


Top News


Related Articles